Jihan Muhaidat, Alsharif Mohammad Fawwaz, Firas Al-Qarqaz, Diala Alshiyab, Ashaar-Akhras, Mohammad Mustafa Ababneh, Alina Ghazou, Shaden Tashtoush, Touga Abdelnabi
{"title":"Moisturizer Use in Children With Atopic Dermatitis: Real-Life Practice, Beliefs, and Challenges Among a Cohort of Jordanian Patients.","authors":"Jihan Muhaidat, Alsharif Mohammad Fawwaz, Firas Al-Qarqaz, Diala Alshiyab, Ashaar-Akhras, Mohammad Mustafa Ababneh, Alina Ghazou, Shaden Tashtoush, Touga Abdelnabi","doi":"10.1111/pde.15821","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Moisturizers are a crucial baseline therapy for atopic dermatitis (AD).</p><p><strong>Objective: </strong>To evaluate the real-life experience of using moisturizers in AD patients and to assess parents' opinions and challenges regarding moisturizer use.</p><p><strong>Methods: </strong>This cross-sectional study used a questionnaire completed by the parents of pediatric AD patients. The assessment questionnaire evaluated demographic factors as well as practices, opinions, and challenges regarding the use of moisturizers in AD treatment. Applying moisturizers twice daily, considered sufficient use, was evaluated across demographic levels using bivariate analysis.</p><p><strong>Results: </strong>A total of 425 patients with AD participated in the study. The median age was 4 years, 51% of patients were female, 61% had moderate to severe AD, 34% had a family history of AD, and 41% of cases reported sufficient moisturizer use. Factors associated with increased frequency of application of moisturizers included younger age at diagnosis, higher parents' educational level, and increased family income. The twice-daily application versus less frequent application was associated with fewer monthly flare-ups (33% vs. 17%, p < 0.001). Overall, 54% of patient guardians believed that moisturizers were necessary for treating AD, 69% considered fragrance-free formulas to be better, and 86% thought there to be a need for counseling from their physician on using moisturizers in AD treatment. Factors undermining the application of moisturizers included the time needed for application, cost, and lack of patient cooperation.</p><p><strong>Conclusion: </strong>In real-world practice, parents tend to underutilize moisturizers. To address this issue, treating physicians must provide additional education, and health insurance companies should consider covering moisturizers to ensure their accessibility.</p>","PeriodicalId":19819,"journal":{"name":"Pediatric Dermatology","volume":" ","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/pde.15821","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Moisturizers are a crucial baseline therapy for atopic dermatitis (AD).
Objective: To evaluate the real-life experience of using moisturizers in AD patients and to assess parents' opinions and challenges regarding moisturizer use.
Methods: This cross-sectional study used a questionnaire completed by the parents of pediatric AD patients. The assessment questionnaire evaluated demographic factors as well as practices, opinions, and challenges regarding the use of moisturizers in AD treatment. Applying moisturizers twice daily, considered sufficient use, was evaluated across demographic levels using bivariate analysis.
Results: A total of 425 patients with AD participated in the study. The median age was 4 years, 51% of patients were female, 61% had moderate to severe AD, 34% had a family history of AD, and 41% of cases reported sufficient moisturizer use. Factors associated with increased frequency of application of moisturizers included younger age at diagnosis, higher parents' educational level, and increased family income. The twice-daily application versus less frequent application was associated with fewer monthly flare-ups (33% vs. 17%, p < 0.001). Overall, 54% of patient guardians believed that moisturizers were necessary for treating AD, 69% considered fragrance-free formulas to be better, and 86% thought there to be a need for counseling from their physician on using moisturizers in AD treatment. Factors undermining the application of moisturizers included the time needed for application, cost, and lack of patient cooperation.
Conclusion: In real-world practice, parents tend to underutilize moisturizers. To address this issue, treating physicians must provide additional education, and health insurance companies should consider covering moisturizers to ensure their accessibility.
期刊介绍:
Pediatric Dermatology answers the need for new ideas and strategies for today''s pediatrician or dermatologist. As a teaching vehicle, the Journal is still unsurpassed and it will continue to present the latest on topics such as hemangiomas, atopic dermatitis, rare and unusual presentations of childhood diseases, neonatal medicine, and therapeutic advances. As important progress is made in any area involving infants and children, Pediatric Dermatology is there to publish the findings.